#stimulation — Thursday, October 15, 2026 (1 items)
| 3 | ℹ |
Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-10-15 | #depression #neuromodulation #clinical trial #stimulation |